Delivery Order 75N93025D00006-75N93026F00002

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 13, 2011, with a ceiling value of $4,399,991.97 for preclinical services in the development of interventional agents for infectious diseases. The order encompasses administrative, technical, and management support activities. Place of performance is Menlo Park, CA. The ultimate completion date is February 15, 2020. Pricing is cost plus fixed fee with no set-aside applied.

The National Institute of Allergy and Infectious Diseases issued a $1,095,062 delivery order to Eurofins Discovery Services North America, LLC on February 25, 2026, for interventional agents safety and pharmacokinetic services, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ vehicle. Place of performance is St. Charles, Missouri. The order carries a firm fixed price structure and ultimate completion date of February 24, 2027. No set-aside was used.

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on April 1, 2020, with a ceiling value of $8.95 million for nonclinical services supporting the development of interventional agents for infectious diseases. The order is issued under the Nonclinical Services for Development of Interventional Agents parent IDIQ. Work is performed in Menlo Park, CA, with an ultimate completion date of March 31, 2021. The contract is priced on a...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order (Task Order C03) to Sri International on February 20, 2026, with a ceiling value of $721,961.69 under a firm fixed price structure.</p> <p>Place of performance is Menlo Park, CA. The order carries an ultimate completion date of February 19, 2032. No set-aside was used.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.

The National Institute of Allergy and Infectious Diseases issued a delivery order to Icon Government and Public Health Solutions, Inc. on December 15, 2019, under the Therapeutics Against Infectious Diseases Phase 1 IDIQ with a ceiling value of $36,748.58. Place of performance is Hinckley, OH. The order is for Phase 1 clinical trial unit services for therapeutics against infectious diseases. The contract is priced on a cost-plus-fixed-fee basis with an ultimate completion date of December 14,...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Dynport Vaccine Company LLC on December 15, 2016, under the Therapeutics Against Infectious Diseases Phase 1 IDIQ for Phase 1 clinical trial unit operations supporting therapeutics against infectious diseases. The order has a ceiling value of $81,323.41 and obligates $99,299 in FY 2017 funds for administrative and overall clinical operations support and concept development, with final completion by December...

<p>The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on June 1, 2021, with a ceiling value of $142,592, under the Nonclinical Services for Development of Interventional Agents IDIQ for nonclinical service training on obtaining an IND (Investigational New Drug application).</p> <p>Place of performance is Menlo Park, CA. The order is firm fixed price with an ultimate completion date of May 31, 2022. No set-aside was used.</p>

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc. on November 30, 2016, under the HIV Microbicides and Biomedical Prevention 2016–2021 IDIQ, with a ceiling value of $530,845.56 for material receipt, storage, shipping, and inventory services. Place of performance is Rockville, Maryland. The order was priced on a cost-plus-fixed-fee basis with an ultimate completion date of July 14, 2023. No set-aside was used.

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on August 25, 2015, exercising Option 4 Year 5 (Period 9/1/2019–8/31/2020) for $1,999,679 in administrative and technical support for radiation/nuclear medical countermeasure product development activities under a cost-plus-fixed-fee structure. The order supports all other task orders under the base contract through administrative and technical activities. Place of performance is Menlo Park,...